Neuroinflammatory and synaptic mechanisms underlying cisplatin neurotoxicity in the cerebrum and hippocampus: roles of oxidative stress and BDNF, NMDAR2B, p-Tau, and Akt/GSK3β signaling
Аннотация
This study investigated the neurotoxic effects of cisplatin on rat cerebrum and hippocampus tissues, focusing on neuroinflammation, oxidative stress, synaptic plasticity, and neurodegeneration. Wistar albino rats were divided into three groups: a control group, a 7.5 mg/kg cisplatin group, and a 12 mg/kg cisplatin group. The control group received isotonic saline, while the treatment groups received a single intraperitoneal dose of cisplatin. At the end of the experiment, cerebrum and hippocampus tissues were collected. Oxidative stress markers (malondialdehyde [MDA], superoxide dismutase [SOD]), inflammatory cytokines (tumor necrosis factor-alpha [TNF-α], interleukin-1beta [IL-1β], interleukin-6 [IL-6], interleukin-10 [IL-10]), and neurodegenerative markers (phosphorylated-tau [p-Tau], brain-derived neurotrophic factor [BDNF], cortisol, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor 1 [AMPA1]) were measured by enzyme-linked immunosorbent assay (ELISA), whereas protein kinase B (Akt1)/glycogen synthase kinase-3 beta (GSK3β) and N-methyl-D-aspartate receptor subunit 2B (NMDAR2B) protein expression levels were analyzed by Western blot. Cisplatin administration caused a significant, dose-dependent increase in pro-inflammatory cytokines (TNF-α and IL-1β; p < 0.001) and a compensatory rise in IL-10 levels ( p < 0.001) in both tissues. Oxidative stress markers, particularly MDA and SOD, were significantly elevated at the higher dose ( p < 0.05). In contrast, BDNF levels ( p < 0.001) and NMDAR2B expression ( p < 0.05), which are essential for neuronal survival and synaptic plasticity, were markedly reduced. Additionally, p-Tau levels ( p < 0.005 in the cerebrum, p < 0.002 in the hippocampus) and cortisol levels significantly increased in the 12 mg/kg group, indicating enhanced neurodegenerative processes. The hippocampus was more sensitive to cisplatin toxicity than the cerebrum, exhibiting significantly elevated IL-6 and SOD levels ( p < 0.05) even at the lower 7.5 mg/kg dose. Overall, the findings demonstrate that cisplatin induces neuroinflammation, oxidative damage, and synaptic dysfunction, leading to activation of neurodegenerative pathways. This heightened vulnerability of the hippocampus may contribute to chemotherapy-associated cognitive impairment.